On Jun 20, BLESER JOSEPH G, Director exercised an option 50,000 shares of MiMedx Group Inc. (NASDAQ: MDXG), with the average selling price of the stock being $0.70 per share. The total amount realized from this exercised an option $35,000. A document was filed with the Securities and Exchange Commission to notify the public about the exercised an option of the shares.
In addition to that, Director – Hack Bruce exercised an option an extra 50,000 shares of this stock in a transaction that took place a day before, on Jun 07, with a share exercised an option at an average of $0.76 and a total of $38,000 was realized from this transaction. After the transaction, the Director – Hack Bruce was left with 757,575 shares of the company’s stock, which is currently worth around $575757.0.
The recent price movement of MDXG means that it is now up by 4.59% from its 52-week high and 667.37% up against its 52-week low prices. Over the past one week, the price volatility of MDXG stands at 8.25% while the volatility over the past one month is 5.70%.
The company on 10/31/2019 published its latest quarterly earnings, with the report showing that the company recorded 0.07 earnings per share (EPS) during that period. This report was below the expectations of analysts of 0.08 by -0.01. The revenue by the firm was 87.75M for the quarter.
The shares of MiMedx Group Inc. (MDXG) gained by 5.35%, leading to a gain of $0.37 per share, and saw MDXG end the trading session at $7.29 on Friday 11/29/19. MDXG started the trading session at $7.05, before reaching a daily high of $7.50. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $7.00.
The trading volume on Friday stood at 702217, which was below the stock’s 3-month average volume of 230.38K shares, out of a total 98.20M shares. As the price of the stock climbed, the market valuation of the company gained to 809.45 million.
The shares of Global Blood Therapeutics Inc. (NASDAQ: GBT) went up by 0.36% by the end of the recent trading session. This movement saw its price surge to close at $66.50, which was higher than the previous closing price of $66.26. Over the past one week, the price of GBT has jumped by 18.71%, while it has recorded a gain of 35.38% over the past one month. Its three-month performance saw GBT gain 44.63% while its six-month performance saw it surge by 13.75%. The situation is different though over the past one year, as the stock price went up by 102.74%, while its year-to-date (YTD) price performance jumped by 62.00%. The stock price has gone up by +50.55% compared to its 90-day low, while it is down -7.56% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Buy. In the short-term, the stock has a 20-day average volume of 1,359,875 shares, with the short-term indicators averagely rating the stock as a 50% Buy. A look at its medium-term indicators reveals that it has a 50-Day average volume of 968,668 shares and the indicators have an average rating of 50% Sell. The last indicators, the long-term see GBT stock with a 100-Day average volume of 853,241 shares, giving it an average rating of 50% Buy. A look at the general picture of all short, medium and long-term indicators leaves GBT with an average rating of 24% Buy.
Several brokerage firms sent out their reports GBT stock not long ago. In its report sent out on November 25, 2019, Cantor Fitzgerald lowered its ratings on GBT to a Overweight. In an earlier report on November 06, 2019, Canaccord Genuity Initiated the stock to a Hold. Goldman meanwhile in its report on May 29, 2019 Resumed its rating of the stock to “Neutral”.
In related news to the company’s stock, around 13.19% shares are being held by institutional investors.